Native Full-Length Membrane Proteins for Drug Discovery

CALIXAR delivers the highest-quality membrane proteins used for drug discovery. Our products and services are adapted to pharmaceutical, biotechnology companies, as well as academic teams that are involved in life science.

Products and services

A world reference in native membrane protein science

Our membrane proteins are among the best in the world for developing new drugs, antibodies, formulating vaccines and discovering primary leads through Structure-Based Drug Design or High Throughput Screening assays.

Membrane protein products and reagents

CALIXAR's pipeline contains native and functional membrane targets ready for the discovery. Our patented technology has a significant impact on membrane protein’s conformity and quality. We have developed surfactant-based detergents that maintain the functional and structural integrity of membrane proteins.

Custom membrane protein production services

CALIXAR guides its clients fin defining the best expression, solubilization, and stabilization conditions for specific targets. Having these challenging membrane proteins stabilized (native and functional) in full length format is crucial to secure the relevance of new leads, and further to increase success in clinical stages.

Pipeline

New membrane protein discovery

CALIXAR’s technology is capable of producing high quality, native, wild-type, unaltered, unmutated and untruncated targets for antibody development and drug discovery projects.
We are unique in the market and are at the forefront of Membrane Protein technology.

Due to our patented technology and expertise, we are able to manufacture membrane proteins that sustain the structure and function of the target. Our membrane proteins are pure, native, unaltered and stable. They can also able bind to a wide and broad scope of compounds including agonists, antagonists, and allosteric modulators.

CALIXAR's pipeline is composed of a wide range of native membrane targets: GPCRs & Receptors, Ion Channels & Enzymes, MDR & AMR Targets. We are continuously developing the most challenging targets to meet the needs of the life science discovery market.

Tagline

Medium length section heading goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

01

Feature one

Feature one

Short heading goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

02

Feature two

Feature two

Short heading goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

03

Feature three

Feature three

Short heading goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

04

Feature four

Feature four

Short heading goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Applications

How we can fit your needs

The CALIXAR® platform utilizes patented technology only available for clients under specific agreements (license, co-development, and service). You can leverage our proprietary technology as well as other best-in-class membrane protein technology that is not available anywhere else on the market.

01
Drug discovery
Drug discovery

Drug discovery

CALIXAR produces native and functional membrane protein targets for the discovery of new hits, leads or compounds with greater affinity.

02
Antibody discovery
Antibody discovery

Antibody discovery

CALIXAR’s technology maintains the structural and functional integrities of the antigen to develop conformational antibodies with therapeutic potential.

03
Structure determination
Structure determination

Structure determination

CALIXAR helps you better understand the mechanisms of action, optimize research leads and solve high-resolution structures or co-structure of membrane proteins.

04
Vaccine discovery
Vaccine discovery

Vaccine discovery

CALIXAR produces high-quality, native, pure, and functional antigens for vaccine discovery.

05
Biological assays
Biological assays

Biological assays

CALIXAR provides high-quality membrane protein biochemical assays and characterization services for scientists and researchers.

Expertise

A unique and native process

Conventional approaches tend to modify the protein through deletions or point mutations to make it adapted to the environment. Instead, CALIXAR’s approach modifies the chemical environment that will adapt to the proteins/antigens chemistry.

Our process permits the preservation of the functional and structural integrities of the targets/antigens. This has a significantly positive result on the quality of the protein and on the success of the proteomics and drug discovery applications.

Better Discovery

Uncover reliable and efficient drugs and antibodies as they are not locked in any particular conformation.

Native Proteins

CALIXAR is the preeminent lab to produce native, wild-type, unmutated and untruncated targets for drug/antibody/vaccine discovery.

Made for Pharma/Biotech

Our high-quality membrane proteins are adapted to application in pharmaceutical, biotechnology firms, and academic teams.

Proprietary Technology

All of our clients gain access to our proprietary technology and expertise. (7 patent families, 20 publications).

Any Life science

Antibodies (nanobodies, scaffold proteins, aptamers, Small molecules, 3D Structures (X-ray or XFEL, Cryo-EM, NMR)

At any stage

Purified membrane proteins are adapted to drug discovery, antibody development and drug validation at any clinical stage.

Media

Latest news, events, press releases and related news

Event
October 20, 2023

Eurofins CALIXAR will attend the 3rd IRN I-GPCRNET Annual Meeting from October 25th to 27th, 2023

News
October 13, 2023

New molecules for the stabilization of membrane proteins, a new research article

Events
April 28, 2023

CALIXAR will attend the Protein & Antibody Engineering Summit (PEGS US) on May 15 – 19 2023 at Boston

Press releases
April 6, 2023

Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise

News
March 24, 2023

Résultats de l’année 2022 - Results of the year 2022

News
March 10, 2023

CALIXAR obtient le renouvellement de son agrément « Crédit d’Impôt Recherche » (CIR) pour 5 ans

Secure and boost
your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.